MedPath

BAY-867548

Generic Name
BAY-867548

PET/MRI to Stage Prostate Cancer Patients

Phase 2
Recruiting
Conditions
Prostate Cancer
Interventions
First Posted Date
2024-07-03
Last Posted Date
2024-07-03
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
50
Registration Number
NCT06484361
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milan, Italy

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2023-04-10
Last Posted Date
2023-04-10
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
60
Registration Number
NCT05806853
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milan, Italy

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Phase 3
Conditions
Breast Cancer
Interventions
Combination Product: LightPath® Imaging System and 68Ga-RM2
First Posted Date
2018-11-06
Last Posted Date
2018-11-06
Lead Sponsor
Lightpoint Medical Limited
Target Recruit Count
80
Registration Number
NCT03731026
Locations
🇬🇧

Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Phase 2
Completed
Conditions
Prostate Adenocarcinoma
Interventions
Procedure: Magnetic Resonance Imaging
Procedure: Positron Emission Tomography
First Posted Date
2015-12-08
Last Posted Date
2023-04-10
Lead Sponsor
Andrei Iagaru
Target Recruit Count
122
Registration Number
NCT02624518
Locations
🇺🇸

Stanford University, School of Medicine, Palo Alto, California, United States

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

Phase 2
Completed
Conditions
Prostate Carcinoma
Interventions
Procedure: Magnetic Resonance Imaging (MRI) scan
Procedure: Positron Emission Tomography (PET) scan
First Posted Date
2015-05-12
Last Posted Date
2017-04-11
Lead Sponsor
Stanford University
Target Recruit Count
10
Registration Number
NCT02440308
Locations
🇺🇸

Stanford University Hospitals and Clinics, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath